CROs/Service Providers

NeuroCog Trials adds staff and office space

Monday, December 5, 2016

NeuroCog Trials, a cognitive services provider for the clinical trials industry, has announced that it is significantly expanding its presence at its headquarters in Durham. Construction is currently underway to give NeuroCog Trials the entire third floor, in addition to their fourth floor space of the SouthCourt building, totaling approximately 22,500 square feet of workspace.

[Read More]

QuintilesIMS to acquire TKL Research’s Clinical Trials Division

Monday, November 21, 2016

TKL Research, a dermatology specialty CRO, has signed an agreement to sell its Clinical Trials Division (CTD) to QuintilesIMS. Upon closing, TKL’s CTD will become part of Novella Clinical, a Quintiles company. Moving forward, TKL Research will retain its Research Clinics Division (RCD) as TKL Research, which operates full-service inpatient and outpatient phase I facilities in northern New Jersey.

[Read More]

CSSi LifeSciences launches fully integrated medical device CRO

Friday, November 18, 2016

CSSi LifeSciences, a trusted partner from discovery to commercialization for drugs and medical devices, announced the establishment and launch of its fully integrated Medical Device CRO. CSSi LifeSciences Medical Device CRO aims to positively impact the timeline of regulatory clearance and increase profitability for medical device companies, in order to successfully launch its innovative research discoveries and product concepts into the market.

[Read More]

Survey: CRO oversight is a challenge for life science companies

Friday, November 18, 2016

Comprehend recently released a survey of over 100 Clinical Operations leaders from some of the most innovative, high-growth and demanding life sciences companies. The survey provides clear consensus on their goals, challenges and best practices for CRO oversight. It provides program, study and vendor oversight teams insights into how their peers are approaching this initiative. The biggest takeaway? Clinical Intelligence provides the CRO oversight and collaboration needed to deliver speed to quality results. 

[Read More]

Almac Group adds 312 jobs

Tuesday, November 15, 2016

Almac Group, a global contract pharmaceutical development and manufacturing organization, announced plans to expand its operations in Europe and North America, increasing its global headcount to reach 5,000 by 2017.

[Read More]

Bionical acquires Global CRO Emas Pharma

Monday, November 14, 2016

Bionical, the integrated outsourced specialist to the pharmaceutical, biotechnology and public health industry, has announced the strategic acquisition of Emas Pharma, a global CRO. Emas, which provides pharmaceutical development and clinical research services to biotech, medical device and specialized pharmaceutical companies worldwide, will join Bionical’s existing fast growing clinical services business. Financials were not disclosed.

[Read More]